Treatment with the UroLift System is typically a one-time, in-office solution that provides rapid relief and recovery of BPH symptoms.
It can break the cycle of medications and how they make a person feel, all without the risks of more invasive surgery. The goal of the UroLift System treatment is to relieve symptoms so you can get back to your life and resume your daily activities.
The UroLift System treatment has demonstrated a significant improvement in quality of life for patients compared to medications. The UroLift System is the only BPH procedure shown not to cause new and lasting erectile or ejaculatory dysfunction, while being a safe and effective treatment of lower urinary tract symptoms due to BPH.
Find your BPH symptom score.
Consult with our world-class medical experts within days of your call.
It is the only BPH treatment performed by a urologist that does not require heating, cutting, or removal of the prostate tissue.
The procedure is typically performed using local anesthesia and patients typically return home the same day without a catheter.
First, the UroLift Delivery Device is placed through the obstructed urethra to access the enlarged prostate.
Then, small UroLift implants are permanently placed to lift and hold the enlarged prostate tissue out of the way and increase the opening of the urethra.
Finally, the UroLift Delivery Device is removed, leaving an open urethra designed to provide symptom relief.
Treatment with the UroLift System typically takes less than one hour, and does not preclude future UroLift System treatments, TURP, or laser procedures.
After the treatment, patients typically go home the same day without a catheter. There is minimal downtime post-treatment and many patients experience symptom relief in as early as 2 weeks. Patients may experience some urinary discomfort during the recovery period.
Effective BPH symptom relief with minimally invasive and low risk treatments.
They include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate and/or the inability to control the urge. Most of these side effects resolve within two to four weeks after the procedure.
There are few long-term risks associated with the UroLift procedure. However, in about 10% of patients, they were required to remove their implants as they were protruding into the bladder, which could cause stone formation if left untreated. Additionally, there is a minor risk of developing a urinary tract infection (UTI) related to cystoscopy procedure, but this is treatable with antibiotics
The UroLift System treatment has been found to be a safe and effective treatment for symptoms related to BPH. Its risk profile is better than reported for most traditional surgical options, and patients report symptom relief better than reported with medications. In the large, pivotal study on the UroLift System, there were no instances of new, sustained erectile dysfunction or ejaculatory dysfunction.
AR
HY
ZH-CN
EN
DE
EL
IT
FA
PT
ES
TR
JP
